Related Experiment Video
Updated: May 11, 2026

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
Published on: January 20, 2019
Inhibitory effects of epigenetic modulators and differentiation inducers on human medulloblastoma cell lines
Ina Patties1, Rolf-Dieter Kortmann, Annegret Glasow
1Department of Radiation Therapy, University of Leipzig, Stephanstraße 9a, Leipzig, 04103, Germany. Ina.patties@medizin.uni-leipzig.de
Background:
Medulloblastoma (MB) is the most common malignant brain tumor in childhood with a 5-year survival of approximately 60%. We have recently shown that treatment of human MB cells with 5-aza-2'-deoxycytidine (5-aza-dC) reduces the clonogenic survival significantly. Here, we tested combinatorial effects of 5-aza-dC with other epigenetic (valproic acid, SAHA) and differentiation-inducing drugs (resveratrol, abacavir, retinoic acid) on human MB cells in vitro to intensify the antitumor therapy further.
Methods:
Three human MB cell lines were treated with 5-aza-dC alone or in combination for three or six days. Metabolic activity was measured by WST-1 assay. To determine long-term reproductive survival, clonogenic assays were performed. Induction of DNA double-strand break (DSB) repair was measured by γH2AX assay.
Results:
The applied single drugs, except for ATRA, reduced the metabolic activity dose-dependently in all MB cell lines. Longer treatment times enhanced the reduction of metabolic activity by 5-aza-dC. Combinatorial treatments showed differential, cell line-dependent responses indicating an important impact of the genetic background. 5-Aza-dC together with resveratrol was found to exert the most significant inhibitory effects on metabolic activity in all cell lines. 5-aza-dC alone reduced the clonogenicity of MB cells significantly and induced DSB with no further changes after adjuvant administration of resveratrol.
Conclusion:
The observed significant decrease in metabolic activity by combinatorial treatment of MB cells with 5-aza-dC and resveratrol does not translate into long-term reproductive survival deficiency in vitro. Further studies in animal models are needed to clarify the resveratrol-mediated anticancer mechanisms in vivo.
Insights
This study investigated combining 5-aza-2'-deoxycytidine (5-aza-dC) with other drugs to treat medulloblastoma (MB). While combinations reduced metabolic activity, they did not significantly impact long-term cancer cell survival in vitro.
Area of Science:
- Oncology
- Cancer Biology
- Epigenetics
Background:
- Medulloblastoma (MB) is a common childhood brain tumor with poor survival rates.
- Previous research indicated 5-aza-2 -deoxycytidine (5-aza-dC) reduces MB cell survival.
- This study aimed to enhance MB therapy by combining 5-aza-dC with other epigenetic and differentiation drugs.
Purpose of the Study:
- To evaluate the combinatorial effects of 5-aza-dC with epigenetic drugs (valproic acid, SAHA) and differentiation-inducing drugs (resveratrol, abacavir, retinoic acid) on human MB cells in vitro.
- To determine if these combinations could intensify antitumor therapy against medulloblastoma.
Main Methods:
- Three human MB cell lines were treated with 5-aza-dC alone or in combination for 3 or 6 days.
- Metabolic activity was assessed using WST-1 assay.
- Clonogenic assays measured long-term reproductive survival, and γH2AX assays detected DNA double-strand break induction.
Main Results:
- Most single drugs, except ATRA, reduced metabolic activity dose-dependently.
- 5-aza-dC combined with resveratrol showed the most significant reduction in metabolic activity across all cell lines.
- While 5-aza-dC alone reduced clonogenicity and induced DNA damage, adding resveratrol did not enhance these effects.
Conclusions:
- Combinatorial treatment with 5-aza-dC and resveratrol significantly decreased metabolic activity but did not translate to reduced long-term survival in vitro.
- Further in vivo studies are necessary to understand resveratrol's anticancer mechanisms against medulloblastoma.
More Related Videos
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Abnormal Proliferation
Mitogens and the Cell Cycle

